LOGO
Investors who suffered losses exceeding $100,000 in Inspire Medical Systems, Inc. (NYSE: INSP) have the opportunity to lead a securities fraud lawsuit against the company. The Rosen Law Firm, an established global investor rights law firm, is reminding affected shareholders that the deadline to apply as lead plaintiff is January 5, 2026.
Individuals who purchased common stock of Inspire Medical between August 6, 2024 and August 4, 2025 may be eligible for compensation through a contingency fee arrangement, meaning they will not incur any out-of-pocket expenses. Interested investors can join the class action by visiting the firm’s website or contacting attorney Phillip Kim directly.
The lawsuit alleges that during the specified period, Inspire Medical misrepresented key information regarding its sleep apnea device, Inspire V. According to the claim, the company failed to disclose the actual market demand for the device and whether it had taken the necessary steps to ensure a successful launch. As a result of the misleading statements, investors were led to believe that demand for Inspire V was robust, which was not the case.
When the true details about the product’s market viability emerged, investors reportedly suffered significant financial losses. Those wishing to serve as lead plaintiff will need to formally apply to the court by the deadline.
The Rosen Law Firm emphasizes the importance of selecting experienced legal counsel. The firm has a solid track record in handling securities class actions, having previously achieved the largest settlement against a Chinese company in such cases. Their expertise is reflected in their ranking as the top firm by ISS Securities Class Action Services for the number of settlements reached in 2017, and they have consistently ranked in the top tier since then.
In 2019 alone, the firm secured over $438 million for investors. Founding partner Laurence Rosen has been recognized as a Titan of the Plaintiffs’ Bar by Law360, highlighting the firm’s credibility and success in securities litigation.
Investors considering joining the class action are advised that no class has been certified yet. Until certification occurs, individuals are not represented unless they retain legal counsel. They can also choose to remain as absent class members without taking any action at this time. An investor’s potential recovery will not hinge on serving as a lead plaintiff.
For further information on joining the Inspire Medical class action, individuals can visit the Rosen Law Firm’s website or reach out via phone or email.
This announcement serves as a critical reminder for investors to stay informed about their legal options, especially in cases of alleged securities fraud.
